Publicaciones en las que colabora con Manuel Hermida Prieto (23)

2020

  1. Circulating miR-181a-5p as a new biomarker for acute cellular rejection in heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 39, Núm. 10, pp. 1100-1108

2019

  1. AGT haplotype in ITGA4 gene is related to antibody-mediated rejection in heart transplant patients

    PLoS ONE, Vol. 14, Núm. 7

2018

  1. Donor polymorphisms in genes related to B-cell biology associated with antibody-mediated rejection after heart transplantation

    Circulation Journal, Vol. 82, Núm. 5, pp. 1351-1359

  2. Polymorphisms in genes related to the complement system and antibody-mediated cardiac allograft rejection

    Journal of Heart and Lung Transplantation, Vol. 37, Núm. 4, pp. 477-485

2016

  1. Analysis of variants in the HCN4 gene and in three single nucleotide polymorphisms of the CYP3A4 gene for association with ivabradine reduction in heart rate: A preliminary report

    Cardiology Journal, Vol. 23, Núm. 5, pp. 573-582

2009

  1. Gene Expression Profiling for Monitoring Graft Rejection in Heart Transplant Recipients

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2240-2243

2008

  1. Sirolimus treatment of left ventricular hypertrophy: Who, and when?

    European Heart Journal

2007

  1. Identification of a cardiac allograft rejection marker using microarray gene expression analysis in lymphocytes from heart transplant patients [4]

    Revista Espanola de Cardiologia

2005

  1. Detection of HCV-RNA in saliva of HIV-HCV coinfected patients

    AIDS Research and Human Retroviruses, Vol. 21, Núm. 12, pp. 1011-1015

  2. HCV clearance patterns in saliva and serum of patients with chronic HCV infection under interferon plus ribavirin therapy

    Journal of Oral Pathology and Medicine, Vol. 34, Núm. 5, pp. 308-311

2004

  1. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations

    American Journal of Cardiology, Vol. 94, Núm. 1, pp. 50-54

2002

  1. Detection of HCV RNA in saliva of patients with hepatitis C virus infection by using a highly sensitive test

    Journal of Virological Methods, Vol. 101, Núm. 1-2, pp. 29-35

  2. Familial dilated cardiomyopathy in patients transplanted for idiopathic dilated cardiomyopathy

    Revista Espanola de Cardiologia, Vol. 55, Núm. 7, pp. 725-732

  3. Microchimerism after heart transplantation: Prevalence, predisposing factors, natural history, and prognosis

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 161-163

  4. Whole stimulated salivary flow in patients with chronic hepatitis C virus infection

    Journal of Oral Pathology and Medicine, Vol. 31, Núm. 2, pp. 117-120

2001

  1. Removal of bowel aerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural α-Galactosyl IgG antibodies

    Xenotransplantation, Vol. 8, Núm. 1, pp. 15-23

2000

  1. Absence of enteroviral RNA in hearts explanted from patients with dilated cardiomyopathy

    Journal of Heart and Lung Transplantation, Vol. 19, Núm. 2, pp. 134-138

1999

  1. Long-term re-treatment with interferon and ribavirin combination therapy in patients with chronic hepatitis C who are non-responders to interferon alone: A preliminary study

    Scandinavian Journal of Infectious Diseases, Vol. 31, Núm. 4, pp. 359-361

  2. Sustained decrease of serum anti-galactose α1-3-galactose antibodies in baboons by removing aerobic gram-negative bacteria from the bowel

    Transplantation Proceedings

1997

  1. The efficacy of interferon alfa treatment in chronic hepatitis C in relation to the serum concentration of RNA-HCV and the viral genotype

    Anales de medicina interna (Madrid, Spain : 1984), Vol. 14, Núm. 10, pp. 500-505